Adimab

Founded 2007
Founders Errik Anderson K. Dane Wittrup Tillman Gerngross

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$193M
Portfolio companies 1
Rounds per year 0.14
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Key employees Soon

Areas of investment

  • Therapeutics
  • Pharmaceutical
  • Biotechnology

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Adimab:
Typical Co-investors
Adimab is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Adimab:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Lambda Prime United States, Boston
Level 3 Communications United States, Broomfield
MITAC International Corp Taiwan, Taoyüan
MKS Switzerland, Geneva
Dyadic International United States, Jupiter
360 Jinrong China, Shanghai
Luxor Capital Group United States, New York
On Grid Ventures United States, New York
Smollan South Africa, NA - South Africa
HH SPR-XV HK Holdings China, Hong Kong Island
Pfm Capital Canada, Regina
WE Hub India, Hyderabad
Esta Investment Russia, Moscow
Beijing Langzi Asiana Asset Management -
Exchange -
Abbhi Capital United States, Coral Gables
University of North Carolina at Chapel Hill - Crunchbase School Profile & Alumni United States, Chapel Hill
Reykjavik University -
Avoro Ventures -

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Adagio Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
1
$336M19 Apr 2021 United States, " United States"}

Adagio Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
1
$50M16 Jul 2020 United States, " United States"}

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Adimab?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: